1. A145 EFFICACY AND SAFETY OF UPADACITINIB MAINTENANCE THERAPY IN PATIENTS WITH MODERATELY TO SEVERELY ACTIVE ULCERATIVE COLITIS: RESULTS FROM A RANDOMIZED PHASE 3 STUDY. (21st February 2022) Authors: Panaccione, R; Danese, S; Zhouwen, W; Pangan, A; Hébuterne, X; Nakase, H; D'Haens, G; Panes, J; Lindsay, J; Higgins, P; Loftus, E; Sandborn, W; Xie, W; Sanchez gonzalez, Y; Liu, J; Weinreich, M; Vermeire, S Journal: Journal of the Canadian Association of Gastroenterology Issue: Volume 5(2022)Supplement 1 Page Start: 18 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. A37 EFFICACY AND SAFETY OF RISANKIZUMAB AS MAINTENANCE THERAPY IN PATIENTS WITH CROHN'S DISEASE: 52 WEEK RESULTS FROM THE PHASE 3 FORTIFY STUDY. (21st February 2022) Authors: Panaccione, R; Ferrante, M; Feagan, B G; Sandborn, W; Panes, J; Peyrin-Biroulet, L; Colombel, J; Schreiber, S; Dubinsky, M; Baert, F; Hisamatsu, T; Neimark, E; Huang, B; Liao, X; Song, A; Berg, S; Duan, W; Pang, Y; Pivorunas, V; Kligys, K Journal: Journal of the Canadian Association of Gastroenterology Issue: Volume 5(2022)Supplement 1 Page Start: 43 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. DOP057 ECCO-EBMT joint paper: autologous haematopoietic stem cell transplantation (AHSCT) in severe Crohn's disease: Summary of the ECCO-EBMT joint review. (16th January 2018) Authors: Snowden, J; Panes, J; Alexander, T; Allez, M; Ardizzone, S; Dierickx, D; Finke, J; Hasselblatt, P; Hawkey, C; Kazmi, M; Lindsay, J; Onida, F; Salas, A; Saccardi, R; Vermeire, S; Rovira, M; Ricart, E Journal: Journal of Crohn's and colitis Issue: Volume 12:Number 1(2018:Jan.)Supplement 1 Page Start: S070 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. DOP53 Clinical, endoscopic, histological and biomarker activity following treatment with the gut-selective, pan-JAK inhibitor TD-1473 in moderately to severely active ulcerative colitis. (25th January 2019) Authors: Sandborn, W; Nguyen, D; Ferslew, B; Hao, L-Y; Kanno, T; Tomsho, L; Boyle, D; Graham, R; Abhyankar, B; Panes, J Journal: Journal of Crohn's and colitis Issue: Volume 13(2019)Supplement 1 Page Start: S060 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. DOP57 Predictive modelling to examine long term treatment effectiveness of darvadstrocel in patients with complex perianal fistulas in Crohn's Disease. (27th May 2021) Authors: Maruszczak, M; Genenz, K; Turkstra, E; Fenu, E; Hantsbarger, G; Gilaberte, I; Karki, C; Panes, J Journal: Journal of Crohn's and colitis Issue: Volume 15(2021)Supplement 1 Page Start: S092 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. Lifestyle, behaviour, and environmental modification for the management of patients with inflammatory bowel diseases: an International Organization for Study of Inflammatory Bowel Diseases consensus. (July 2022) Authors: Ananthakrishnan, Ashwin N; Kaplan, Gilaad G; Bernstein, Charles N; Burke, Kristin E; Lochhead, Paul J; Sasson, Alexa N; Agrawal, Manasi; Tiong, Jimmy Ho Tuan; Steinberg, Joshua; Kruis, Wolfgang; Steinwurz, Flavio; Ahuja, Vineet; Ng, Siew C; Rubin, David T; Colombel, Jean-Frederic; Gearry, Richard... Journal: Lancet gastroenterology and hepatology Issue: Volume 7:Number 7(2022) Page Start: 666 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. OP20 The effects of upadacitinib on ulcerative colitis symptom resolution and fatigue normalization in patients with moderately to severely active ulcerative colitis: Phase 3 U-ACHIEVE and U-ACCOMPLISH results. (30th January 2023) Authors: D'Haens, G; Tran, J; Danese, S; Rubin, D T; Aoyama, N; Lügering, A; Klaff, J; Xuan, S; Ilo, D; Sanchez Gonzalez, Y; Panes, J Journal: Journal of Crohn's and colitis Issue: Volume 17(2023)Supplement 1 Page Start: i27 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. OP23 Efficacy and safety of upadacitinib as induction therapy in patients with Moderately to Severely Active Ulcerative Colitis: Results from phase 3 U-ACCOMPLISH study. (27th May 2021) Authors: Vermeire, S; Danese, S; Zhou, W; Pangan, A; Greenbloom, S; D'Haens, G; Panes, J; Juillerat, P; Lindsay, J O; Loftus Jr, E V; Sandborn, W J; Reinisch, W; Sanchez Gonzalez, Y; Huang, B; Xie, W; Liu, J; Weinreich, M A; Panaccione, R Journal: Journal of Crohn's and colitis Issue: Volume 15(2021)Supplement 1 Page Start: S021 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
9. OP23 The efficacy and safety of guselkumab induction therapy in patients with moderately to severely active Ulcerative Colitis: Phase 2b QUASAR Study results through week 12. (21st January 2022) Authors: Dignass, A; Rubin, D; Bressler, B; Huang, K H; Shipitofsky, N; Germinaro, M; Zhang, H; Johanns, J; Feagan, B; Sandborn, W; Sands, B; Hisamatsu, T; Lichtenstein, G; Panes, J; Allegretti, J Journal: Journal of Crohn's and colitis Issue: Volume 16(2022)Supplement 1 Page Start: i025 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
10. OP28 The effect of guselkumab induction therapy on early clinical outcome measures in patients with Moderately to Severely Active Crohn's Disease: Results from the phase 2 GALAXI 1 study. (27th May 2021) Authors: Danese, S; Sandborn, W J; Feagan, B G; Weisel, K; Gonzalez, S; Frustaci, M E; Yang, Z; Johanns, J; Germinaro, M; Afzali, A; Andrews, J M; D'Haens, G; Hisamatsu, T; Panaccione, R; Reinisch, W; Rubin, D T; Sands, B E; Panes, J Journal: Journal of Crohn's and colitis Issue: Volume 15(2021)Supplement 1 Page Start: S027 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗